As we step into 2025, the Frequency Research Foundation continues to address the evolving challenges posed by the evolved COVID Flu. Originally detected in early 2023, this formidable pathogen has not only persisted but also adapted, significantly impacting individuals and environments worldwide.
The Evolution from 2023 to Present
The journey of this COVID flu began over a year ago when we first encountered its complex nature. Initially resembling typical flu variants, it soon revealed a broader spectrum of associated pathogens, including viruses, bacteria, and parasites. This complexity often caused prolonged illnesses, lasting several months without comprehensive frequency treatment to eliminate all underlying pathogens.
In November 2024 we found a significantly evolved version of this flu in a few clients in the United States. Coming into January 2025 it has spread to our European clients. Stealth COVID variants were found that cripple the mitochondria and sap all energy from the body. Some bacterial pathogens are causing severe swelling of glands and lymph nodes. Multiple parasites host the flu pathogens and until they are all eliminated the flu repeats itself through internal reinfection. It is highly contagious and it is easy to get reinfected from external exposure to buildings or people who carry the flu.
Understanding the Complex Syndrome
Today’s COVID flu transcends typical respiratory infections by embedding itself into our surroundings, infecting buildings and other indoor environments, making eradication particularly challenging. The persistence of this flu is partly due to airborne parasites that act as vectors, carrying the pathogen across various environments and thus facilitating continued cycles of infection and reinfection.
Breakthroughs in Frequency Research
One groundbreaking discovery involved a client who experienced repeated infections triggered by physical activity. Investigations revealed that certain parasites were releasing flu pathogens during exertion. By targeting these parasites with specific frequencies, we successfully halted the reinfection process, underscoring the nuanced approach needed for this flu variant.
Check out our podcast on these disruptive innovations!
Providing Free Access to Frequency Sets
In line with our commitment to public health, the Frequency Research Foundation offers free access to advanced frequency sets, significantly enhanced by AI for increased effectiveness. These sets are designed to target a wide range of pathogens identified in the ongoing COVID flu crisis, including:
- Multiple SARS-CoV-2 variants
- Parasites like Giardia
- Various bacteria and viruses responsible for respiratory infections
- Newly identified pathogens contributing to the syndrome’s complexity
Refining Our Approach
Our frequency sets are continuously updated with the latest data from global DNA sequencing efforts, ensuring that our interventions are both swift and precise. This proactive approach is vital in managing such a dynamic and persistent health threat.
Beyond Traditional Prevention Methods
Previous strategies such as mask-wearing and standard sanitization proved insufficient against the multifaceted nature of the current COVID flu. Our comprehensive strategy now includes regular environmental screenings and targeted frequency treatments, aiming to break the cycle of reinfection effectively.
Fostering Global Collaboration
By freely sharing our frequency sets and providing comprehensive support through our clinics, we encourage a unified global response to this health crisis. This collaborative effort is essential for refining treatment methods and expediting recovery on a worldwide scale.
As we face this evolved health threat, the Frequency Research Foundation remains dedicated to advancing frequency-based therapies. We continue to explore innovative solutions to tackle this complex challenge and invite further collaboration to enhance global health resilience.